Adhansia XR

DRUG2 trials

Sponsors

Purdue Pharma LP

Conditions

Attention Deficit/Hyperactivity DisorderAttention-Deficit/Hyperactivity Disorder

Phase 4

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

TerminatedNCT04507204

Purdue Pharma LPAttention-Deficit/Hyperactivity Disorder

Start: 2020-07-30End: 2022-01-31Updated: 2023-07-27

Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

TerminatedNCT04987762

Purdue Pharma LPAttention Deficit/Hyperactivity Disorder

Start: 2021-08-03End: 2022-04-27Updated: 2023-08-22